Skip to main content

Detail

Karlheinz Hilber
Assoc. Prof. Dr. Karlheinz Hilber

Center for Physiology and Pharmacology (Division of Neurophysiology and Neuropharmacology)
Position: Associate Professor

T +43 1 40160 31230
karlheinz.hilber@meduniwien.ac.at

Keywords

Arrhythmias, Cardiac; Calcium Channels, L-Type; Cardiac Electrophysiology; Cardiomyopathy, Dilated; Muscular Dystrophy, Duchenne; Voltage-Gated Sodium Channels

Research group(s)

  • Cardiac electrophysiology and pharmacology

Research interests

  • Cardiac ion channel impairments in the diseased heart
  • Effects of drugs on cardiac ion channels

Techniques, methods & infrastructure

whole cell patch clamp technique, isolation of cardiomyocytes from neonatal and adult mouse and guinea pig hearts, human induced pluripotent stem cell- derived cardiomyocytes, muscular dystrophy mouse models, standard biochemistry and molecular biology 

Members of this research group have access to a cell culture, a standard biochemistry and molecular biology lab, and a patch clamp rig.

Grants

  • Cardiac calcium channel abnormalities in Duchenne Muscular Dystrophy (2017)
    Source of Funding: FWF (Austrian Science Fund), Stand-Alone Projects
    Principal Investigator
  • Voltage-gated ion channel dysfunction in dystrophic muscle (2010)
    Source of Funding: FWF (Austrian Science Fund), Stand-Alone Projects
    Principal Investigator
  • Cardiogenic substances (2009)
    Source of Funding: aws (Austria Wirtschaftsservice), PRIZE
    Principal Investigator
  • Ion channel plasticity in transforming skeletal muscle (2006)
    Source of Funding: FWF (Austrian Science Fund), Stand-Alone Projects
    Principal Investigator
  • Na channels in fast and slow skeletal muscle (2001)
    Source of Funding: FWF (Austrian Science Fund), Stand-Alone Projects
    Principal Investigator

Selected publications

  1. Rubi, L. et al., 2015. Proper Voltage-Dependent Ion Channel Function in Dysferlin-Deficient Cardiomyocytes. Cell Physiol Biochem, 36(3), pp.1049-1058. Available at: http://dx.doi.org/10.1159/000430278.
  2. Koenig, X. & Hilber, K., 2015. The Anti-Addiction Drug Ibogaine and the Heart: A Delicate Relation. Molecules, 20(2), pp.2208-2228. Available at: http://dx.doi.org/10.3390/molecules20022208.
  3. Koenig, X. et al., 2013. Enhanced currents through L-type calcium channels in cardiomyocytes disturb the electrophysiology of the dystrophic heart. AJP: Heart and Circulatory Physiology, 306(4), pp.H564-H573. Available at: http://dx.doi.org/10.1152/ajpheart.00441.2013.
  4. Koenig, X. et al., 2012. Anti-addiction drug ibogaine inhibits hERG channels: a cardiac arrhythmia risk. Addiction Biology, 19(2), pp.237-239. Available at: http://dx.doi.org/10.1111/j.1369-1600.2012.00447.x.
  5. Koenig, X. et al., 2011. Voltage-Gated Ion Channel Dysfunction Precedes Cardiomyopathy Development in the Dystrophic Heart M. Rota, ed. PLoS ONE, 6(5), p.e20300. Available at: http://dx.doi.org/10.1371/journal.pone.0020300.